Your browser is no longer supported. Please, upgrade your browser.
Settings
HTBX Heat Biologics, Inc. daily Stock Chart
HTBX [NASD]
Heat Biologics, Inc.
Index- P/E- EPS (ttm)-1.52 Insider Own1.00% Shs Outstand26.56M Perf Week-1.59%
Market Cap23.00M Forward P/E- EPS next Y-0.76 Insider Trans0.00% Shs Float24.17M Perf Month3.10%
Income-15.60M PEG- EPS next Q-0.07 Inst Own6.60% Short Float10.37% Perf Quarter-14.26%
Sales0.20M P/S115.00 EPS this Y-38.60% Inst Trans47.31% Short Ratio1.92 Perf Half Y-36.79%
Book/sh0.36 P/B2.41 EPS next Y-15.20% ROA-140.50% Target Price4.00 Perf Year20.28%
Cash/sh0.32 P/C2.71 EPS next 5Y- ROE-316.00% 52W Range0.40 - 3.35 Perf YTD0.70%
Dividend- P/FCF- EPS past 5Y-48.20% ROI- 52W High-74.15% Beta0.78
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin- 52W Low116.50% ATR0.09
Employees24 Current Ratio2.70 Sales Q/Q- Oper. Margin- RSI (14)45.99 Volatility8.71% 9.43%
OptionableNo Debt/Eq0.40 EPS Q/Q86.50% Profit Margin- Rel Volume0.69 Prev Close0.87
ShortableYes LT Debt/Eq0.11 EarningsApr 06 BMO Payout- Avg Volume1.31M Price0.87
Recom2.00 SMA20-3.08% SMA50-5.79% SMA200-22.13% Volume905,343 Change-0.46%
Jun-20-16Initiated ROTH Capital Buy
Jan-08-16Initiated Noble Financial Buy $16
May-26-15Initiated H.C. Wainwright Buy $13
Sep-18-13Initiated Aegis Capital Buy $36
Mar-24-17 06:07AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen
Mar-23-17 01:35PM  2 Health Care Stocks Crushed on Thursday -15.53%
08:00AM  Heat Biologics Prices Offering of 5,000,000 Shares of Common Stock GlobeNewswire
07:50AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
Mar-22-17 04:04PM  Heat Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-21-17 09:41AM  Heat Biologics Lung Cancer Drug Posts Good Results at Investopedia +6.45%
07:03AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Heat Biologics Reports Positive Interim Phase 2 Lung Cancer Results in Patients Treated with HS-110 in Combination with a Checkpoint Inhibitor GlobeNewswire
Mar-20-17 07:00AM  Heat Biologics, Inc. to Present at The MicroCap Conference on April 4th in New York City Accesswire +5.68%
Mar-16-17 04:55PM  Heat Biologics faces threat of delisting again at bizjournals.com
07:02AM  Florida Department of Health Awards Three-Year Grant to Develop gp96-based Zika Vaccine GlobeNewswire
07:01AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa
Mar-13-17 03:30PM  Heat Biologics Lung Cancer Drug Combo Succeeds at Investopedia +7.78%
07:03AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2 GlobeNewswire
Mar-09-17 09:35AM  Austin cancer-fighting startup to rejoin public company it spun out from in 2012 at bizjournals.com +9.52%
08:15AM  Blog Coverage Heat Biologics Acquires Controlling Stake in Immuno-Oncology Company Pelican Therapeutics Accesswire
08:00AM  Heat Biologics to Present at 29th Annual ROTH Conference GlobeNewswire
Mar-08-17 02:56PM  Durham outfit to acquire Texas company in a cash-stock deal at bizjournals.com
07:00AM  Heat Biologics Announces Agreement to Acquire Pelican Therapeutics GlobeNewswire
Mar-02-17 08:00AM  Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Feb-21-17 03:01PM  Heat Biologics offers further bladder cancer treatment outlook at bizjournals.com
Feb-17-17 07:00AM  Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium GlobeNewswire
Feb-14-17 08:00AM  Heat Biologics to Present at the Genitourinary Cancers Symposium GlobeNewswire
Feb-03-17 06:05AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-27-17 12:17PM  These 5 Stocks Under $10 Could Get Hot Soon +14.89%
Jan-24-17 08:00AM  Heat Biologics to Present at NobleCon13 GlobeNewswire
Jan-17-17 11:08AM  Heat Biologics to reap benefit of new biotech at bizjournals.com +5.56%
Jan-06-17 08:02AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +7.95%
Jan-05-17 08:00AM  Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco GlobeNewswire
Jan-04-17 04:32PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Defini
08:00AM  Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer GlobeNewswire
Dec-09-16 04:01PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement -5.83%
Dec-06-16 04:45PM  Heat Biologics stock active on heels of lung, bladder cancer results at bizjournals.com +8.11%
11:16AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:20AM  Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results GlobeNewswire
Dec-01-16 10:38PM  Biotech Movers: Heat Biologics Inc (HTBX) And Achaogen Inc (AKAO) at Insider Monkey -64.11%
04:02PM  Rosen Law Firm Closes Investigation and Concludes There is No Basis for Securities Claims Against HTBX Business Wire
03:18PM  These Stocks Gained More Than 100% in November
02:18PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heat Biologics, Inc. (HTBX) PR Newswire
01:14PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Heat Biologics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
11:52AM  INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Heat Biologics, Inc. - HTBX Business Wire
10:23AM  Heat Biologics Stock Falls on Negative Bladder Cancer Data
06:08AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-30-16 05:28PM  Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting GlobeNewswire
Nov-28-16 03:30PM  Biotech Movers And Shakers: Heat Biologics Inc (HTBX) and Sunshine Heart Inc (SSH) at Insider Monkey +29.72%
08:25AM  Heat Biologics (HTBX) in Focus: Stock Moves 30.4% Higher
Nov-18-16 01:04PM  HEAT BIOLOGICS, INC. Financials
Nov-17-16 07:00AM  Heat Biologics to Present Topline HS-110/Nivolumab Combination Phase Ib Lung Cancer Results at the International Society for the Study of Lung Cancer Annual Meeting GlobeNewswire -6.00%
Nov-16-16 07:00AM  Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at the Society of Urological Oncology Annual Meeting GlobeNewswire
Nov-14-16 07:00AM  Heat Biologics Presents ComPACT Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting GlobeNewswire +9.02%
Nov-11-16 10:39AM  Heat Biologics losses decrease after cuts in R&D, workforce and salary deferrals at bizjournals.com
Nov-10-16 04:47PM  Heat Biologics Provides Corporate Update and Reports Third Quarter 2016 Financial Results GlobeNewswire
04:05PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:05PM  HEAT BIOLOGICS, INC. Files SEC form 10-Q, Quarterly Report
Nov-07-16 07:00AM  Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire +6.15%
Oct-31-16 01:54PM  Heat Biologics CEO Interview Abuzz With Zika Developments: Collaboration, Vaccine And Other Initiatives
Oct-26-16 06:22PM  Durham-based Heat Biologics CEO talks new Zika collaboration at bizjournals.com +11.28%
Oct-25-16 07:00AM  Heat Biologics and University of Miami Announce Zika Vaccine Collaboration GlobeNewswire
Oct-17-16 07:30AM  Heat Biologics to Present at Two Upcoming Investor Conferences and Panel Discussion GlobeNewswire
Oct-13-16 07:00AM  Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter GlobeNewswire -6.02%
Oct-11-16 07:30AM  Heat Biologics Selects Adaptive Biotechnologies to Discover Potential Clinical Biomarkers to Advance Novel Immunotherapies GlobeNewswire
Oct-07-16 07:00AM  Heat Biologics Substantially Reduces Debt and Reports Proceeds of Approximately $2.8 Million Year-to-Date from the Exercise of Warrants GlobeNewswire -6.77%
Oct-06-16 04:03PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Sep-14-16 07:00AM  Heat Biologics Resumes Enrollment in its Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combination with Anti-PD-1 Checkpoint Inhibitor GlobeNewswire
Sep-13-16 01:38PM  3 Medical Stocks Under $10 to Buy Now
07:00AM  Heat Biologics to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-18-16 08:02AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Other Events
Aug-15-16 04:30PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:21PM  HEAT BIOLOGICS, INC. Files SEC form 10-Q, Quarterly Report
04:15PM  Heat Biologics Provides Corporate Update and Reports Second Quarter 2016 Financial Results GlobeNewswire
Aug-08-16 02:17PM  Rising Oil, Strong Earnings Have Several Energy Stocks Jumping Today at Insider Monkey +38.17%
Jul-22-16 03:51PM  Heat Biologics Suspends Planned Public Offering -14.94%
08:10AM  Heat Biologics suspends proposed common stock public offering the day after announcing it at MarketWatch
08:00AM  Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock GlobeNewswire
Jul-21-16 04:15PM  Heat Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire -13.00%
04:01PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Change in Directors or
Jul-07-16 07:00AM  Heat Biologics Announces Cancer Immunology Research Publication Featuring its ComPACT Platform Technology GlobeNewswire
Jul-01-16 07:02AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-20-16 07:49AM  Coverage initiated on Heat Biologics by ROTH Capital
Jun-06-16 07:08AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -13.85%
07:00AM  Heat Biologics Presents a Poster on its HS-110/Nivolumab Combination Phase 1b Non-Small Cell Lung Cancer Trial at ASCO Annual Meeting GlobeNewswire
May-27-16 07:13AM  7 Stocks Under $10 to Trade for Big Profits
May-11-16 07:12AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi -6.56%
07:00AM  Heat Biologics Reports First Quarter 2016 Financial Results GlobeNewswire
May-03-16 04:36PM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa
Apr-26-16 07:00AM  Heat Biologics to Present at PIONEERS 2016, Presented by Joseph Gunnar & Co. GlobeNewswire
Apr-25-16 08:25AM  8 Breakout Stocks Under $10 to Trade for Big Profits at TheStreet +5.88%
07:54AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:00AM  Heat Biologics Appoints Dr. John Prendergast to Board of Directors GlobeNewswire
Apr-18-16 06:00AM  OncoSec and Heat Biologics Present Data at the American Conference for Cancer Research (AACR) Annual Meeting PR Newswire
06:00AM  Heat Biologics and OncoSec Present Data at the American Conference for Cancer Research (AACR) Annual Meeting GlobeNewswire
Apr-15-16 03:10PM  The best-run public companies in the Research Triangle area at bizjournals.com
09:00AM  Targeting an $11 Billion Market, Heat Biologics' Cancer Vaccines Provide Investors a Huge Opportunity Accesswire
Apr-12-16 06:00AM  Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Apr-07-16 01:44PM  Durham's Heat Bio to lay off 22% of workforce, reduce trial enrollment at bizjournals.com
07:11AM  HEAT BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Costs Associated with Exit or Di
07:00AM  Heat Biologics Announces Cost-Saving Measures and Focused Corporate Strategy to Achieve Important Clinical Milestones GlobeNewswire
Mar-30-16 07:20AM  Heat Biologics to Participate in the 6th Annual Cancer Immunotherapy: A Long-Awaited Reality Conference at noodls
07:00AM  Heat Biologics to Participate in the 6th Annual Cancer Immunotherapy: A Long-Awaited Reality Conference GlobeNewswire
Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.